Presentation · Sep 2025 · PDF
Presentations & Publications
Achondroplasia
Presentation · Dec 2024 · PDF
Infigratinib - ISDS 2024 - Clinical Development Program Update
Presentation · Dec 2024 · PDF
BBIO - Infigratinib - PROPEL 2 Data Update and ACCEL Program Initiation
Presentation · Dec 2023 · PDF
Infigratinib - ESPE 2023 - Updated Six Month Results in Phase 2 Cohort 5 Study
Presentation · Dec 2023 · PDF
Infigratinib - ENDO 2023 - Updated Six Month Results in Phase 2 Cohort 5 Study
Presentation · Dec 2023 · PDF
Infigratinib - ENDO 2023 - Murine Models in Achondroplasia and Hypochondroplasia
Presentation · Dec 2023 · PDF
Infigratinib - ENDO 2023 - PROPEL, PROPEL 2 and PROPEL OLE
Presentation · Dec 2023 · PDF
Infigratinib - ENDO 2023 -Evaluation of Bone Mineral Density
Presentation · Dec 2023 · PDF
infigratinib - PROPEL2 Topline Results
Publication · Feb 2021 · PDF
Bone, Lifetime Impact of Achondroplasia: Current Evidence and Perspectives on the Natural History
Publication · 2019 · PDF
Orphanet Journal of Rare Diseases, Achondroplasia: A Comprehensive Clinical Review
Publication · Dec 2016 · PDF